Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07804706) titled 'Preoperative Neutrophil-to-Albumin Ratio and Post-Induction Hemodynamic Vulnerability in Major Oncologic Surgery' on Sept. 1.
Study Type: Observational
Primary Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Condition:
Hemodynamic Instability
Post-induction Hypotension (PIH)
Recruitment Status: Recruiting
Date of First Enrollment: September 1, 2026
Target Sample Size: 200
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07804706
Disclaimer: Curated by HT Syndication....